Founded in 2017 and headquartered in the high-tech heart of Shenzhen, China, Shenzhen BioX Medical Co., Ltd. has rapidly emerged as a globally recognized leader in the molecular diagnostic landscape. We specialize in the development of sophisticated molecular diagnostic analysis systems, genetic testing solutions, and advanced clinical laboratory equipment.
With a state-of-the-art manufacturing facility spanning over 9,000 square meters and a dedicated professional workforce exceeding 200 employees, we represent the pinnacle of Chinese medical engineering. Our mission is to bridge the gap between complex biotechnology and practical clinical application, providing hospitals, research institutions, and public health organizations with the tools they need for rapid, accurate disease detection.
The global diagnostic landscape is undergoing a seismic shift toward Point-of-Care Testing (POCT) and high-throughput automation. Shenzhen BioX Medical's technology roadmap is designed to meet these challenges head-on. By integrating Artificial Intelligence (AI) for data interpretation and Peltier-driven thermal cycling for rapid PCR results, we are setting new standards for analytical precision.
Implementing machine learning algorithms to automate the interpretation of complex fluorescence data, reducing human error in qPCR and genetic sequencing.
Developing 12-channel and 24-channel simultaneous detection systems to identify multiple pathogens from a single clinical sample, vital for respiratory panels.
Building cloud-based laboratory management modules that sync diagnostic results across hospital networks in real-time for enhanced patient care.
As a premier China Healthcare Testing Solutions Exporter, Shenzhen BioX Medical leverages the unique advantages of the Shenzhen industrial cluster. This "Silicon Valley of Hardware" allows us to maintain an agile supply chain that can pivot rapidly to meet global health crises.
Efficiency Advantages:
1. Vertical Integration: From component molding to PCB assembly and optical calibration, over 80% of our production processes are handled in-house or within a 50km radius.
2. Cost-Performance Ratio: By optimizing laboratory workflows and utilizing advanced automation in our 9,000 sqm facility, we offer premium technologies at a total cost of ownership that is 30-40% lower than Western counterparts.
3. Rapid Prototyping: Our multidisciplinary team of engineers can move from concept to functional prototype in half the time of traditional manufacturers, ensuring our clients always have the latest technology.
High-throughput PCR systems for centralized hospital laboratories requiring 24/7 reliability.
Portable, rapid detection kits for livestock and pets, localized for field-use across diverse climates.
Intelligent sampling platforms for grain and food safety inspections at points of entry and trade.
Diagnostic tools for cable fault detection and water purification monitoring in heavy industry.
Committed to Excellence
Every unit undergoes 100+ hours of stress testing before export.
BioX Medical
